Title for MeetingAbstracts
Alphabetical listing of titles
CD8+ cells are major contributors to elevated IFNg gene expression in HIV infection.
CD8+ cells exposed to B7.2 but not B7.1 during activation have an increased ability to suppress HIV replication.
CD8+ CTL induced in AIDS vaccine evaluation group phase I trials using canarypox vectors (ALVAC) encoding multiple HIV gene products (vCP125, vCP205, vCP300) given with or without subunit boost.
CD8+ CTL response and virus fitness during primary infection with HIV-1.
CD8+ cytotoxic T cells are target of HIV infection in vivo.
CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.
CD8+ lymphocyte stimulation in HIV-infected patients.
CD8+ lymphocyte-mediated suppression of human immunodeficiency virus type 1 expression in human brain cells.
CD8+ lymphocyte-mediated suppression of human immunodeficiency virus type 1 expression in human brain cells. Neuroscience of HIV Infection.
CD8+ lymphocytes are the critical cells mediating suppression of HIV release by CD4+ cells.
CD8+ lymphocytes can control acute HIV infection of CD4+ T cells.
CD8+ lymphocytes contribute to control of SIV infection and resistance to rechallenge facilitated by transient early antiretroviral treatment.
CD8+ lymphocytes count during AZT therapy in patients with persistent generalized lymphadenopathy.
CD8+ lymphocytes from HCV/HBV patients are able to inhibit HIV replication.
CD8+ lymphocytes from HIV-1 seropositive individuals block HIV replication in CD4+ lymphocytes by inhibiting viral RNA synthesis.
CD8+ lymphocytes from SIV-infected rhesus macaques recognize 27 different epitopes bound by the MHC class I molecule mamu-A*01: implications for vaccine design and testing.
CD8+ lymphocytes inhibit HIV-1 replication in acutely and chronically infected-lymphoblastoid cell line.
CD8+ rather than CD4+ lymphocytes control reactivation of chronic toxoplasmosis in murine immunodeficiency models.
CD8+ S6F1+ and CD8+ CD56+ cells in peripheral blood of recently infected HIV-1 IVDUs.
CD8+ T cell apoptosis in HIV infected people results from costimulatory interactions with monocytes.
CD8+ T cell culture fluids from HIV-infected individuals suppress HIV-1 long terminal repeat (LTR) driven transcription.
CD8+ T cell markers studied with dual immunofluorescence in various stages of HIV infection in haemophiliacs.
CD8+ T cell responses represent a major force driving HIV-1 evolution.
CD8+ T cell-mediated inhibition of HIV replication in vitro correlates with clinical stage of the disease.
CD8+ T cell-mediated suppression of HIV replication: relevance of known chemokines and other cytokines.
CD8+ T cell-mediated suppression of HIV-1 in patients receiving the protease inhibitor indinavir and/or stavudine.
CD8+ T cell-mediated suppression of HIV-1 replication in the PBMC of asymptomatic HIV-1 carriers.
CD8+ T cells can suppress HIV replication VIA a soluble factor.
CD8+ T CELLS CONTROL REPLICATION OF NONPATHOGENIC SHIV89.6 IN SOME, BUT NOT ALL RHESUS MACAQUES - A ROLE FOR INNATE RESPONSES?
CD8+ T cells mediate resistance to HIV challenge in SCID mice engrafted with PBL of long term non-progressors.